3783 results for «2026»
3783 results
Euro4C 2026 - Registration rates
10 Sep 2025
Check out what's included in the onsite packages of the Annual meeting dedicated to Contemporary Care of Patients with Calcified Complex Lesions.
⚠️ Registration alert: please use our official platform to register for Euro4C. PCR Courses organisers cannot be held responsible for any issue encountered when using third-party...
Industry Partners at AICT-AsiaPCR
Organise your trip to Paris!
Innovation in action at #PCRID
Training Village Programme
AICT-AsiaPCR: Everything ready for your trip?
Innvolution Healthcare reports one-year findings from the ALCHEMY study evaluating Eternia in 1000 patients at EuroPCR 2026
27 May 2026
Concept medical announces preliminary 3-year SIRONA data at Charing Cross Symposium 2026
21 Apr 2026
Jupiter endovascular announces positive results from SPIRARE II pivotal trial at EuroPCR 2026
20 May 2026
EuroPCR 2026 – Outcomes with left atrial appendage closure vs. direct oral anticoagulants in patients with atrial fibrillation across different age groups
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a subgroup analysis of the CHAMPION-AF trial investigating stroke-prevention strategies...
EuroPCR 2026: Elixir Medical's DynamX® bioadaptor demonstrates significantly lower event rates than drug-eluting stent in long-term follow-up, including reduction in cardiovascular death
19 May 2026
20 years of TEER: a journey at the crossroads of the human heart
20 Nov 2023 – From PCR London Valves 2023
In 2023, with 200,000 MitraClips performed, the session concluded by posing the question of how many M-TEERs would be conducted by 2026. While the answer remains a mystery until PCR LV 2026, explore the fascinating history of transcatheter edge-to-edge mitral valve repair in this session. Delve...
PCR London Valves 2025 – Best of the edition
Outcomes in patients with atrial fibrillation randomized to receive LAA closure or oral anticoagulation: Primary results of the CHAMPION-AF clinical trial
28 Mar 2026
During the first Late-Breaking Trial session of the 2026 ACC Congress held in New Orleans, Saibal Kar, principal investigator of the CHAMPION-AF trial, presented the 3-year results of this groundbreaking study, which were simultaneously published in the NEJM (DOI: 10.1056/NEJMoa2517213).
Author
Long-term mortality following PCI with DES vs. CABG for left main disease
21 May 2026 – From EuroPCR 2026
This major late-breaking trial from EuroPCR 2026 presents a landmark patient-level meta-analysis comparing PCI with drug-eluting stents (DES) versus CABG for left main coronary artery disease. Combining long-term data from the EXCEL, NOBLE, PRECOMBAT, and SYNTAX trials, the analysis found remarkably similar mortality outcomes between the...
Outcomes of LAA closure vs. DOAC in patients with atrial fibrillation across different age groups
21 May 2026 – From EuroPCR 2026
This major late-breaking trial from EuroPCR 2026 highlights new insights from the CHAMPION AF study, one of the largest randomised trials comparing left atrial appendage closure (LAAC) with direct oral anticoagulants (DOACs) in patients with atrial fibrillation. In this interview, Philippe Garot and Jens Erik Nielsen-Kudsk...
What does ORBITA CTO tell us about CTO PCI?
20 May 2026 – From EuroPCR 2026
Chronic total occlusions (CTOs) remain a key area of uncertainty in interventional cardiology, particularly regarding symptom improvement after PCI.
In this EuroPCR 2026 interview, John Davies and Sarosh Khan discuss the ORBITA CTO trial and its implications for clinical practice.
As the first double-blind, placebo-controlled randomised trial in...
ARTICA: Coronary revascularisation in patients undergoing TAVI - an individual patient data meta-analysis of 4 randomised trials
21 May 2026 – From EuroPCR 2026
At EuroPCR 2026, Martin Leon and Roberto Scarsini review ARTICA, a patient-level meta-analysis combining data from the ACTIVATION, NOTION-3, FAITAVI, and TCW randomised trials.
The analysis included 1,050 patients with severe aortic stenosis and concomitant coronary artery disease and compared three management strategies: medical therapy, angiography-guided PCI,...
Early evidence from a next generation coronary sinus reducer for the treatment of coronary microvascular dysfunction
20 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session presents early clinical experience with a next-generation self-expanding nitinol coronary sinus reducer for patients with coronary microvascular dysfunction. It reviews practical aspects of device implantation and discusses initial findings from the SERRA I feasibility study, providing insight into this emerging therapeutic approach....
DK Score Pro in focus: innovation, evidence, and everyday practice
20 May 2026 – From EuroPCR 2026
Watch this EuroPCR 2026 session to better understand how lesion preparation strategies can be optimised in complex PCI using directional scoring balloon technology with DK Score Pro.
Clinical evidence is reviewed, including insights from the SCORE CHINA registry, alongside practical considerations for integrating this approach into routine...
